SOURCE: Implant Science Corporation

March 09, 2005 12:44 ET

Implant Sciences Announces Live Demonstrations of Next Generation Explosive Detection Device in West Palm Beach on March 10 - 11

Lunch and Dinner Company Presentation Today

WAKEFIELD, MA -- (MARKET WIRE) -- March 9, 2005 -- Implant Sciences Corporation (AMEX: IMX)(IMX.WS), a developer, manufacturer and seller of products for homeland security, semiconductor, and medical device industries, today announced the Company will host a lunch and dinner on March 9, 2005, bringing current and potential investors up-to-date on recent developments on the Company's explosives detection, semiconductor and radiation therapy businesses. Dave Volpe, V.P. of Strategic Development for Implant Sciences Corporation, will conduct live demonstrations of the Quantum Sniffer at the Radisson Suite Inn Palm Beach Airport Executive Suite Room 416 on Thursday, March 10, 2005, and Friday, March 11th. The locations and times are as follows:

Wednesday, March 9th, 2005
12:00PM EST
Ft. Lauderdale Marina Marriott
1881 SE 17th Street
Ft. Lauderdale, FL 33316

Wednesday, March 9th, 2005
6:30PM EST
Boca Raton Marriott
5150 Town Center Circle
Boca Raton, FL 33486

Thursday, March 10th, 2005
10AM, 12PM, 4PM
Radisson Suite Inn Palm Beach Airport
Executive Suite Room 416
1808 South Australian Ave
West Palm Beach, FL 33409

Friday, March 11th, 2005
10AM, 12PM, 4PM
Radisson Suite Inn Palm Beach Airport
Executive Suite Room 416
1808 South Australian Ave
West Palm Beach, FL 33409
The Company has now received orders for fourteen (14) QS-H100 explosives detection devices and has qualified international prospects for an additional 100 units in Europe, the Middle East and Asia/Pacific countries. The Company also stated publicly in their Q2 2005 conference call that they expect to announce a strategic partnership with a Company who will distribute the Quantum Sniffer domestically and internationally.

Interested parties can reserve a seat for each presentation by calling the Aurelius Consulting Group at: 407-644-4256, or by registering online at: http://www.runonideas.com/pressReleases/IMX0304200501.html

About Implant Sciences

Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The Company has developed and commercialized portable and bench-top trace element detection devices to identify explosives. In addition, the Company recently received an FDA 510k approval for its new radioactive source for the use in the treatment of breast cancer. For further details on the Company and its products please visit the Company's website at www.implantsciences.com.

Implant Sciences believes that this release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission.

Contact Information